BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29050165)

  • 1. [Ovarian tumor associated with anti-N-methyl-D-aspartate receptor encephalitis: a report of 15 cases].
    Li XM; Jiang HY; Wang YF; Qiu W; Wang Y; Wu HT
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(37):2932-2935. PubMed ID: 29050165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ovarian teratoma associated with anti-N-methyl-D-aspartate receptor encephalitis: a report of 5 cases and review of the literature].
    Zhou X; Sun D; Feng L; Guo L; Ren H; Xue X; Liu Z; Leng J; Zhu L; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):281-6. PubMed ID: 24969336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical characteristics and outcomes of mechanically ventilated patients with anti-N-methyl-D-aspartate receptor encephalitis].
    Zhang Y; Su YY; Gao DQ; Ye H
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):187-192. PubMed ID: 28162168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
    Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment principles of ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis.
    Bai Y; Guan Q; Jiang J; Zhang Z
    Arch Gynecol Obstet; 2016 Sep; 294(3):623-9. PubMed ID: 27056053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of anti
    Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of five case reports of ovarian teratoma withanti-N-methyl-D-aspartate receptor encephalitis.
    Li C; Meng F; Gong S
    Ann Palliat Med; 2021 Apr; 10(4):4950-4954. PubMed ID: 33440951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NMDAR Encephalitis of 11 Cases in China - Detailed Clinical, Laboratory and Imagiological Description.
    Liu J; Wang D; Xiong Y; Liu B; Liu M
    Eur Neurol; 2015; 74(1-2):73-8. PubMed ID: 26277996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
    Hongzhi G; Weize K; Bin P; Yan H; Qiang L; Yuan J; Qing L; Hang S; Haitao R; Yicheng Z; Dawei S; Liying C
    Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):996-1001. PubMed ID: 26506710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
    Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
    J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma: two cases report and anesthesia considerations.
    Liu H; Jian M; Liang F; Yue H; Han R
    BMC Anesthesiol; 2015 Oct; 15():150. PubMed ID: 26475263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-N-methyl-D-aspartate receptor encephalitis with an imaging-invisible ovarian teratoma: a case report.
    Abdul-Rahman ZM; Panegyres PK; Roeck M; Hawkins D; Bharath J; Grolman P; Neppe C; Palmer D
    J Med Case Rep; 2016 Oct; 10(1):296. PubMed ID: 27776544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-N-methyl-D-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: Clinical features, treatment, and prognostic outcomes.
    Zhang L; Lu Y; Xu L; Liu L; Wu X; Zhang Y; Zhu G; Hong Z
    Seizure; 2020 Feb; 75():55-62. PubMed ID: 31874360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
    Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal rank of clinical characteristics and prognosis of anti-N-methyl-d-aspartate receptor encephalitis.
    Yang R; Ge F; Jiang J; Wang Y; Wan M; Zhang W
    Brain Behav; 2021 Aug; 11(8):e2277. PubMed ID: 34232562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian teratoma-associated anti-NMDAR encephalitis: a single-institute series of six patients from China.
    Yu M; Li S; Cheng J; Zhou L; Jiang Z; Di W
    Arch Gynecol Obstet; 2021 May; 303(5):1283-1294. PubMed ID: 33216164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
    de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-N-Methyl-d-Aspartate receptor (NMDAR) encephalitis during pregnancy: Clinical analysis of reported cases.
    Shi YC; Chen XJ; Zhang HM; Wang Z; Du DY
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):315-319. PubMed ID: 28600040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
    Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
    Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian immature teratoma.
    Sameshima A; Hidaka T; Shima T; Nakashima A; Hasegawa T; Saito S
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1883-6. PubMed ID: 21995685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.